UroGen’s Chief Medical Officer Sold $400,000 in Stock After a 191% Run
Key Points According to this Form 4 filing, the CMO of UroGen Pharma sold 10,000 shares at $40.00 per share,…
Key Points According to this Form 4 filing, the CMO of UroGen Pharma sold 10,000 shares at $40.00 per share,…
Key Points Some high-profile dividend ETFs have delivered gains of more than 400% over the past 15 years. There’s no…
Key Points OpenAI originally planned to go public in late 2026, but it now looks like that won’t happen until…
Key Points Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.57…
Key Points Microsoft’s Azure revenue grew 40% year over year in its most recent quarter. The company’s commercial backlog roughly…
Key Points The total disposition of 95,046 shares included the sale of 20,000 shares and a gift of 75,046 shares.…
The latest episodes, articles, and market insights, delivered to your inbox. No noise, just signal.
Join 25,000+ readers. No spam, ever.
Eagle One Intelligence
Macro shifts, market structure, and the ideas worth tracking — straight to your inbox before the crowd figures it out.